Progranulin in neurodegenerative dementia
Citations Over TimeTop 10% of 2021 papers
Abstract
Long-term or severe lack of protective factors is important in the pathogenesis of neurodegenerative dementia. Progranulin (PGRN), a neurotrophic factor expressed mainly in neurons and microglia, has various neuroprotective effects such as anti-inflammatory effects, promoting neuron survival and neurite growth, and participating in normal lysosomal function. Mutations in the PGRN gene (GRN) have been found in several neurodegenerative dementias, including frontotemporal lobar degeneration (FTLD) and Alzheimer's disease (AD). Herein, PGRN deficiency and PGRN hydrolytic products (GRNs) in the pathological changes related to dementia, including aggregation of tau and TAR DNA-binding protein 43 (TDP-43), amyloid-β (Aβ) overproduction, neuroinflammation, lysosomal dysfunction, neuronal death, and synaptic deficit have been summarized. Furthermore, as some therapeutic strategies targeting PGRN have been developed in various models, we highlighted PGRN as a potential anti-neurodegeneration target in dementia.
Related Papers
- → Towards a nosology for frontotemporal lobar degenerations—A meta-analysis involving 267 subjects(2007)161 cited
- → Current Concepts in the Classification and Diagnosis of Frontotemporal Lobar Degenerations: A Practical Approach(2013)15 cited
- Frontotemporal dementia or frontotemporal lobar degeneration--overview of a group of proteinopathies.(2010)
- [The concept of frontotemporal lobar degeneration].(2002)